The synergistic antitumor activity of 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) and anti-PD-L1 antibody inducing immunogenic cell death

Cancer immunotherapy is a strategy that is moving to the frontier of cancer treatment in the current decade. In this study, we show evidence that 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs), act as immunogenic cell death (ICD) inducers, stimulating an antitumor response...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Xiao-Chuan, Peng, Li-Yuan, Yao, Xin, Xu, Mei-Qi, Li, Hui, Zhang, Shuai-Qiang, Li, Zhuo-Yue, Wang, Jing-Ru, Feng, Zhen-Han, Wang, Guang-Xue, Liao, Ai, Chen, Ying, Zhang, Xuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079060/
https://www.ncbi.nlm.nih.gov/pubmed/33866918
http://dx.doi.org/10.1080/10717544.2021.1909180

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8079060/
https://www.ncbi.nlm.nih.gov/pubmed/33866918
http://dx.doi.org/10.1080/10717544.2021.1909180

Ejemplares similares